تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

سعر ريبافيرين شراب 100مل 2022

Ribavirin syrup 100ml

معلومات الدواء

التفاصيل الكاملة
دواعي الاستعمالUses
  • In combination with interferon alfa-2b (pegylated or non-pegylated) for chronic hepatitis C in patients 3 years and older with compensated liver disease; ribavirin monotherapy is not effective for CHC.DailyMed (U.S. National Library of Medicine)
  • In combination with interferon alfa-2b (pegylated or non-pegylated) for chronic hepatitis C in patients 3 years and older with compensated liver disease; ribavirin monotherapy is not effective for CHC.DailyMed (U.S. National Library of Medicine)
الآثار الجانبيةSide effects
  • Hemolytic anemia occurred in more than 10% of adults receiving ribavirin with peginterferon/interferon alfa-2b.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Most common adverse reactions (40% or more) in adults on combination therapy: injection site reaction, fatigue/asthenia, headache, rigors, fever, nausea, myalgia and anxiety/emotional lability/irritability.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Hemolytic anemia occurred in more than 10% of adults receiving ribavirin with peginterferon/interferon alfa-2b.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Most common adverse reactions (40% or more) in adults on combination therapy: injection site reaction, fatigue/asthenia, headache, rigors, fever, nausea, myalgia and anxiety/emotional lability/irritability.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
موانع الاستعمالContraindications
  • Pregnancy; ribavirin may cause fetal harm and is contraindicated in women who are pregnant or planning pregnancy.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Men whose female partners are pregnant.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Known hypersensitivity reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis or erythema multiforme to ribavirin or any component.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
عرض الكل (7)
  • Pregnancy; ribavirin may cause fetal harm and is contraindicated in women who are pregnant or planning pregnancy.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Men whose female partners are pregnant.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Known hypersensitivity reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis or erythema multiforme to ribavirin or any component.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
Show all (7)
تحذيرات واحتياطاتWarnings & precautions
  • Boxed warning - embryo-fetal toxicity: significant teratogenic/embryocidal effects in all animal species; avoid pregnancy and use effective contraception during therapy and for 9 months after treatment in female patients and for 6 months in female partners of male patients.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Boxed warning - hemolytic anemia, which may worsen cardiac disease and has led to fatal and nonfatal myocardial infarction; patients with significant or unstable cardiac disease should not be treated.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Ribavirin monotherapy is not effective for chronic hepatitis C and should not be used alone for this indication.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
عرض الكل (4)
  • Boxed warning - embryo-fetal toxicity: significant teratogenic/embryocidal effects in all animal species; avoid pregnancy and use effective contraception during therapy and for 9 months after treatment in female patients and for 6 months in female partners of male patients.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Boxed warning - hemolytic anemia, which may worsen cardiac disease and has led to fatal and nonfatal myocardial infarction; patients with significant or unstable cardiac disease should not be treated.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Ribavirin monotherapy is not effective for chronic hepatitis C and should not be used alone for this indication.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
Show all (4)
التداخلات الدوائيةDrug interactions
  • DidanosineIncreased exposure to didanosine active metabolite; fatal hepatic failure, peripheral neuropathy, pancreatitis and lactic acidosis reported; coadministration contraindicated.DailyMed (U.S. National Library of Medicine)
  • Nucleoside reverse transcriptase inhibitorsHepatic decompensation (some fatal) in cirrhotic HIV/HCV co-infected patients; monitor closely for toxicities including anemia.DailyMed (U.S. National Library of Medicine)
  • AzathioprineSevere pancytopenia reported; ribavirin inhibits IMPDH and may increase azathioprine-related myelotoxicity.DailyMed (U.S. National Library of Medicine)
  • DidanosineIncreased exposure to didanosine active metabolite; fatal hepatic failure, peripheral neuropathy, pancreatitis and lactic acidosis reported; coadministration contraindicated.DailyMed (U.S. National Library of Medicine)
  • Nucleoside reverse transcriptase inhibitorsHepatic decompensation (some fatal) in cirrhotic HIV/HCV co-infected patients; monitor closely for toxicities including anemia.DailyMed (U.S. National Library of Medicine)
  • AzathioprineSevere pancytopenia reported; ribavirin inhibits IMPDH and may increase azathioprine-related myelotoxicity.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعةPregnancy & breastfeeding
  • Contraindicated in pregnant women and in men whose female partners are pregnant; animal data show teratogenic and/or embryocidal effects, and Ribavirin Pregnancy Registry data showed higher birth-defect rates than background.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • No data on presence of ribavirin in human milk or effects on the breastfed infant; weigh benefits of breastfeeding against maternal need and potential infant risk.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Contraindicated in pregnant women and in men whose female partners are pregnant; animal data show teratogenic and/or embryocidal effects, and Ribavirin Pregnancy Registry data showed higher birth-defect rates than background.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • No data on presence of ribavirin in human milk or effects on the breastfed infant; weigh benefits of breastfeeding against maternal need and potential infant risk.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
كيف يعمل الدواءHow it works
  • Nucleoside (guanosine) analogue antiviral; per the US label the mechanism by which ribavirin contributes to antiviral efficacy against HCV is not fully understood.
  • Ribavirin: Nucleoside (guanosine) analogue antiviral; per the US label the mechanism by which ribavirin contributes to antiviral efficacy against HCV is not fully understood.

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.